Categorie
Uncategorized

(Argentina/Russia) Argentina complains to Russia over vaccine delivery (Euractiv)

Euractiv writes: Argentina has complained to Russia about delays in delivering second doses of its Sputnik V coronavirus vaccine in a letter warning of breach of contract repercussions, the government in Buenos Aires said Thursday (22 July). go to Euractiv: Argentina complains to Russia over vaccine delivery – EURACTIV.com

Categorie
Uncategorized

(Europe/Germany) Half of Europeans vaccinated as Germany warns on rising virus cases (Euractiv)

Euractiv writes: More than half of all European adults are now fully vaccinated, the EU said on Thursday (22 July), as countries across Europe and Asia battled fresh outbreaks blamed on the fast-spreading Delta variant. go to Euractiv: Half of Europeans vaccinated as Germany warns on rising virus cases – EURACTIV.com

Categorie
Uncategorized

Vaccine/Pandemic/G7 – The G7 Vaccine Charade (James K. Galbraith, Project-Syndicate)

The US and Europe are offering low- and middle-income countries crumbs, so that they can protect their billionaires, their pharmaceutical lobbies, and their campaign contributions. This has created an opening for China and Russia – and both are rushing into the breach. The G7 Vaccine Charade by James K. Galbraith – Project Syndicate (project-syndicate.org)

Categorie
Uncategorized

Vaccine/Pandemic – Vaccine Hesitancy or Systemic Racism? (Tian Johnson, Stephaun E. Wallace, Maaza Seyoum, Project-Syndicate)

Minority communities and developing-country populations may approach health services cautiously – and with good reason, given the medical profession’s history of inhumanity. But, by blaming low COVID-19 vaccination rates on vaccine hesitancy, the profession is effectively using this history to victimize the same communities again. Vaccine Hesitancy or Systemic Racism? by Tian Johnson, Stephaun E. […]

Categorie
Uncategorized

TechInnovation – Centering equity in vaccine delivery: How digital technologies can combat vaccine hesitancy and misinformation among women and marginalized communities (Sharada Srinivasan, Danielle Robinson, World Bank blogs)

© World Bank / Curt Carnemark This blog is from a series on digital safeguards and enablers for COVID-19 vaccine delivery. As COVID-19 vaccine rollout advances globally, countries must address issues around vaccine hesitancy and the spread of misinformation. Inaccurate information about COVID-19 has caused people, especially, women and marginalized communities around the world to be wary […]

Categorie
Uncategorized

G7/Vaccine – The G7’s vaccine pledge is a ‘big help’, but what about distribution and delivery? (John Letzing, WEF)

The G7 pledged to dramatically increase vaccine donations to developing countries. But serious challenges remain in terms of distributing the doses necessary to protect everyone. “A big help, but we need more.” That was the director-general of the WHO’s reaction to a pledge made last weekend by some of the wealthiest nations on Earth to ramp up donations of […]

Categorie
Uncategorized

(China/Vaccine) The Vaccine Race: China Expands its Global Influence (INSS)

Hiddai Segev, Galia Lavi Many countries are looking to the COVID-19 vaccines with the hope of overcoming the pandemic and beginning economic recovery. While the drug companies in the West operate as independent for-profit businesses, in China the government directs the research and development efforts of both state and privately owned companies, and uses them as […]

Categorie
Uncategorized

(Pandemic/Vaccine) The value of a vaccine to end COVID-19 is worth between 5% and 15% of wealth (Viral Acharya, Timothy Johnson, Suresh Sundaresan, Steven Zheng, VOXEU)

Quantifying the economic damage caused by the COVID-19 pandemic and the worth of a cure can assist cost-benefit analyses of potential public-sector investment to alleviate the impact of the current pandemic. By reflecting forward-looking expectations, stock prices should indicate the economic value of progress being made towards vaccine development. This column estimates the value of […]

Categorie
Uncategorized

(Pandemic/Vaccine) Why philanthropists must support a free COVID vaccine (Rosalind McKenna, WEF)

Deals between pharmaceutical companies and rich countries enlarge chasms of inequity. We will not recover from COVID-19 until we ensure vaccine access to all people, in all countries, without delay. The People’s Vaccine Alliance urges that vaccines are made available for all people, in all countries, free of charge. https://www.weforum.org/agenda/2021/01/philanthropy-must-support-people-vaccine/

Categorie
Uncategorized

(Pandemic/Digital Technologies/Vaccine) Digital technologies and vaccine deployment: Opportunities and challenges (Boutheina Guermazi, World Bank blogs)

The COVID-19 pandemic has disrupted billions of lives worldwide leading to over 1.8 million deaths while unleashing serious economic hardship with outsized impacts on the poor and precariously employed. But the start of vaccination campaigns around the world now raises hopes for a global recovery. https://blogs.worldbank.org/digital-development/digital-technologies-and-vaccine-deployment-opportunities-and-challenges

Categorie
Uncategorized

PANDEMIC/VACCINE – Vaccine Chimeras (Manjari Mahajan, Global Policy)

The overwhelming prioritization of vaccines takes attention and resources away from the complex political, social and infrastructural investments that underlie a resilient public health response. https://www.globalpolicyjournal.com/blog/22/12/2020/vaccine-chimeras  

Categorie
Uncategorized

POOR COUNTRIES – Can Poor Countries Avoid a Vaccine Bidding War? (Anne O. Krueger, Project-Syndicate)

For all of the good news about the arrival of safe and effective COVID-19 vaccines, the hard truth for the coming year is that global demand will outpace supply. Without a multilateral agreement to allocate doses globally, the road to recovery will be much longer than it otherwise could have been. https://www.project-syndicate.org/commentary/covid-vaccine-allocation-to-developing-countries-by-anne-krueger-2020-12